Mubasher TV
Contact Us Advertising   العربية

EIPICO logs EGP 388.37m profit in H1

EIPICO logs EGP 388.37m profit in H1
Sales increased to EGP 1.44 billion in the six-month period ended June
EIPICO
PHAR
-2.36% 46.00 -1.11

Cairo – Mubasher: Egyptian International Pharmaceutical Industries (EIPICO) on Tuesday posted an EGP 388.37 million in consolidated profits for the first half of 2018, slightly up 0.04% from EGP 388.2 million in H1-17.

Sales increased to EGP 1.44 billion in the six-month period ended June, versus EGP 1.20 billion in the year-ago period, the company said in a filing to the Egyptian Exchange (EGX).

Meanwhile, standalone profits dropped to EGP 368.57 million at the end of June, compared to EGP 371.844 million in H1-17.

It is worth noting that EIPICO logged EGP 183.9 million in consolidated profits for Q1-18, versus EGP 157.8 million in the prior-year period, including minority shareholders’ rights.